"Cell Line, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cell line derived from cultured tumor cells.
| Descriptor ID |
D045744
|
| MeSH Number(s) |
A11.251.210.190 A11.251.860.180
|
| Concept/Terms |
Cell Line, Tumor- Cell Line, Tumor
- Cell Lines, Tumor
- Line, Tumor Cell
- Lines, Tumor Cell
- Tumor Cell Lines
- Tumor Cell Line
|
Below are MeSH descriptors whose meaning is more general than "Cell Line, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Cell Line, Tumor".
This graph shows the total number of publications written about "Cell Line, Tumor" by people in this website by year, and whether "Cell Line, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 9 | 9 |
| 2004 | 0 | 20 | 20 |
| 2005 | 1 | 22 | 23 |
| 2006 | 0 | 29 | 29 |
| 2007 | 0 | 28 | 28 |
| 2008 | 0 | 39 | 39 |
| 2009 | 0 | 53 | 53 |
| 2010 | 0 | 39 | 39 |
| 2011 | 0 | 52 | 52 |
| 2012 | 0 | 27 | 27 |
| 2013 | 0 | 54 | 54 |
| 2014 | 1 | 37 | 38 |
| 2015 | 0 | 57 | 57 |
| 2016 | 0 | 57 | 57 |
| 2017 | 1 | 49 | 50 |
| 2018 | 0 | 49 | 49 |
| 2019 | 0 | 55 | 55 |
| 2020 | 0 | 47 | 47 |
| 2021 | 0 | 41 | 41 |
| 2022 | 0 | 21 | 21 |
| 2023 | 0 | 9 | 9 |
| 2024 | 0 | 25 | 25 |
| 2025 | 0 | 14 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Line, Tumor" by people in Profiles.
-
Resilience and Vulnerabilities of Tumor Cells under Purine Shortage Stress. Clin Cancer Res. 2025 Oct 15; 31(20):4345-4360.
-
Targeting DDR2 for Treating Pancreatic Cancer. Mol Cancer Ther. 2025 Oct 01; 24(10):1570-1583.
-
Using MUC2 mucin producing tumorigenic human goblet-like cells to uncover functional properties of the mucus barrier. Gut Microbes. 2025 Dec; 17(1):2542385.
-
Exosome-Associated MTA1 in Circulation Is Elevated During Breast Cancer Progression. FASEB J. 2025 Jul 31; 39(14):e70872.
-
Mortalin and PINK1/Parkin-Mediated Mitophagy Represent Ovarian Cancer-Selective Targets for Drug Development. Adv Sci (Weinh). 2025 Oct; 12(37):e05592.
-
Novel fusion superkine, IL-24S/IL-15, enhances immunotherapy of brain cancer. J Immunother Cancer. 2025 Jun 22; 13(6).
-
CD51 promotes gastric cancer stemness via blocking Numb-mediated Notch1 degradation. Cancer Lett. 2025 Oct 01; 629:217886.
-
CHD4 drives gastric cancer metastasis via MYH9/GSK3?/?-catenin axis and WNT/EMT pathway activation. Cancer Lett. 2025 Sep 28; 628:217813.
-
P53-Induced Autophagy Degradation of NKX3-2 Improves Ovarian Cancer Prognosis. Cells. 2025 05 22; 14(11).
-
A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity. Proc Natl Acad Sci U S A. 2025 May 06; 122(18):e2427073122.